跳至主要内容
临床试验/NL-OMON48139
NL-OMON48139已完成不适用

Clinical validation of non-invasive tissue perfusion measurements in Vascular diseased patients with PeriFlux 6000 Enhanced Perfusion and Oxygen Saturation (EPOS) system * Pilot study - The VEPOS study

niversitair Medisch Centrum Groningen0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 18 years and older and written informed consent with either;
  • - Healthy volunteer, Rutherford classification 0
  • - Non- critical limb ischemia, Rutherford classification 2 and 3.
  • - Critical limb ischemia, Rutherford classification 4 to 6.

排除标准

  • - Insufficient knowledge of the Dutch language, illiteracy or language barrier
  • - Concurrent uncontrolled medical conditions
  • - Lower leg fractures within the past 12 months.
  • - (Partial) amputation of one of the feet and/or legs.
  • - Pregnant or breast feeding.
  • - Severe peripheral oedema.
  • - Severe cardiac-pulmonary failure.
  • - Active cellulitis-erysipelas of the legs or other dermatological diseases.

研究者

相似试验

Clinical validation of non-invasive tissue perfusion... | 临床试验